Literature DB >> 22032703

Valvular heart disease. The value of 3-dimensional echocardiography.

Roberto M Lang1, Wendy Tsang, Lynn Weinert, Victor Mor-Avi, Sonal Chandra.   

Abstract

Significant advances in 3-dimensional echocardiography (3DE) technology have ushered its use into clinical practice. The recent advent of real-time 3DE using matrix array transthoracic and transesophageal transducers has resulted in improved image spatial resolution, and therefore, enhanced visualization of the pathomorphological features of the cardiac valves compared with previously used sparse array transducers. It has enabled an unparalleled real-time visualization of valves and subvalvular anatomic features from a single volume acquisition without the need for offline reconstruction. On-cart or offline post-processing using commercially available and custom 3-dimensional analysis software allows the quantification of multiple parameters, such as orifice area, prolapse height and volume in mitral valve disease, area of the left ventricular outflow tract, and tricuspid annular geometry. In this review, we discuss the incremental role of 3DE in evaluating valvular anatomic features, volumetric quantification, pre-surgical planning, intraprocedural guidance, and post-procedural assessment of valvular heart disease.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22032703     DOI: 10.1016/j.jacc.2011.07.035

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  16 in total

1.  Lung real time three-dimensional imaging in critically ill ventilated patients: a global diagnosis concordance study.

Authors:  Jean-Marc Le Goff; Claire Roger; Benjamin Louart; Pierre Géraud Claret; Aurélien Daurat; Stéphanie Bulyez; Jean-Yves Lefrant; Xavier Bobbia; Laurent Muller
Journal:  J Clin Monit Comput       Date:  2017-07-14       Impact factor: 2.502

2.  Feasibility of measurements of valve dimensions in en-face-3D transesophageal echocardiography.

Authors:  Sarah Eibel; Edwin Turton; Chirojit Mukherjee; Carmine Bevilacqua; Joerg Ender
Journal:  Int J Cardiovasc Imaging       Date:  2017-05-09       Impact factor: 2.357

Review 3.  Three-dimensional echocardiography of the mitral valve: lessons learned.

Authors:  Francesco Maffessanti; Oana Mirea; Gloria Tamborini; Mauro Pepi
Journal:  Curr Cardiol Rep       Date:  2013-07       Impact factor: 2.931

4.  Three-dimensional compared to two-dimensional transesophageal echocardiography for diagnosis of infective endocarditis.

Authors:  Roman Pfister; Yann Betton; Henrik Ten Freyhaus; Norma Jung; Stephan Baldus; Guido Michels
Journal:  Infection       Date:  2016-05-17       Impact factor: 3.553

Review 5.  Calcific Aortic Valve Disease: Part 1--Molecular Pathogenetic Aspects, Hemodynamics, and Adaptive Feedbacks.

Authors:  Ares Pasipoularides
Journal:  J Cardiovasc Transl Res       Date:  2016-02-18       Impact factor: 4.132

6.  Pathoanatomy of Mitral Regurgitation.

Authors:  Ilya Karagodin; Amita Singh; Roberto M Lang
Journal:  Struct Heart       Date:  2020-06-12

7.  Current clinical applications of transthoracic three-dimensional echocardiography.

Authors:  Luigi P Badano; Francesca Boccalini; Denisa Muraru; Lucia Dal Bianco; Diletta Peluso; Roberto Bellu; Giacomo Zoppellaro; Sabino Iliceto
Journal:  J Cardiovasc Ultrasound       Date:  2012-03-27

Review 8.  Emerging clinical applications of strain imaging and three-dimensional echocardiography for the assessment of ventricular function in adult congenital heart disease.

Authors:  Michael Huntgeburth; Ingo Germund; Lianne M Geerdink; Narayanswami Sreeram; Floris E A Udink Ten Cate
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

Review 9.  Principles of transthoracic echocardiographic evaluation.

Authors:  Anita C Boyd; Nelson B Schiller; Liza Thomas
Journal:  Nat Rev Cardiol       Date:  2015-04-28       Impact factor: 32.419

Review 10.  Interventional echocardiography in structural heart disease.

Authors:  Gila Perk; Itzhak Kronzon
Journal:  Curr Cardiol Rep       Date:  2013-03       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.